Through the fourth amendment to the Patent Law of China in 2020, China established its own pharmaceutical patent linkage system. In December 2021, the Beijing Intellectual Property Court accepted the first pharmaceutical patent linkage lawsuit and issued its decision on April 15, 2022. This presentation will discuss China’s new pharmaceutical patent linkage system, including the legislative process and its current operation in practice. Topics will cover: 

  1. China's legislative progress on the pharmaceutical patent linkage system;
  2. China’s compensation system for the protection period of Chinese pharmaceutical patents;
  3. A brief introduction to the early resolution mechanism of pharmaceutical patent disputes in China;
  4. An introduction to the current operation of China's patent linkage system 

Additional Speaker: Yang Luo at Zhilin Law



CLE is not available when viewing a recording of this program. In order to receive credit you must have attended the live webinar program.

Téléchargements –